MyFinsight
Home
Blog
About
Gross proceeds from
issuance of convertible...
$700,000K
Proceeds from sale of
short-term investments
$241,263K
Proceeds from maturity of
short-term investments
$120,455K
Net income (loss)
$48,508K
Proceeds from issuance of
warrants
$114,100K
Net proceeds from
stock option...
$8,601K
Proceeds from financial
royalty assets
$2,521K
Proceeds from sale of
derivatives
$614K
Share-based compensation
$13,653K
Deferred income taxes,
net
-$12,983K
Depreciation of fixed assets
and amortization of...
$8,215K
Accounts payable and
accrued liabilities
$3,246K
Inventory
-$3,003K
Amortization of debt discount
and issuance fees
$823K
Other assets and
liabilities
-$773K
Lease amortization
expense
$480K
Net cash provided by
financing activities
$546,434K
Net cash provided by
(used in) investing...
$321,117K
Net cash provided by
(used in) operating...
$24,018K
Effect of exchange rate
changes on cash and cash...
$39K
Canceled cashflow
$276,267K
Canceled cashflow
$43,736K
Canceled cashflow
$67,666K
Net increase
(decrease) in cash, cash...
$891,608K
(19323.98%↑ Y/Y)
Purchase of convertible
senior notes hedge
$195,790K
Repurchase of common stock
$60,000K
Debt discount and
payment of debt issuance...
$20,125K
Taxes paid related to
net share...
$345K
Payments under finance
lease obligations
$7K
Purchases of short-term
investments
$37,148K
Purchases of derivatives
$2,672K
Acquisition of financial
royalty assets
$2,640K
Purchases of other
investments
$1,250K
Purchases of property and
equipment
$26K
Loss from change in
fair value of...
$35,727K
Accounts receivable
$13,850K
(gain) loss from
short-term investments
$11,754K
Non-cash income from
financial royalty assets
$2,068K
(gain) loss on
derivative instruments
$1,369K
Accretion of short-term
investments
$1,199K
Change in estimated
fair value of...
$1,116K
Cecl adjustment to
financial royalty assets
-$222K
Other
-$188K
Income tax receivable
and payable
$173K
Net increase
(decrease) in cash, cash...
$891,608K
Back
Back
Cash Flow
LIGAND PHARMACEUTICALS INC (LGNDZ)
LIGAND PHARMACEUTICALS INC (LGNDZ)
source: myfinsight.com